Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease September 2017 | PubMed
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques September 2017 | Science
Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease September 2017 | PubMed
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease September 2016 | PubMed
Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease January 2015 | Karger
Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation November 2014 | PubMed